How quickly does Effexor (venlafaxine) work for hot flashes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effexor (Venlafaxine) for Hot Flashes: Onset of Action

Venlafaxine begins working for hot flashes within 1-2 weeks, with significant effects seen after 4 weeks of treatment, reducing hot flash frequency and severity by 37-61% depending on dosage. 1, 2

Efficacy Timeline and Dosing

  • First week: Initial effects may begin (starting at 37.5mg daily)
  • By week 4: Full therapeutic effect established
    • 37.5mg daily: 37% reduction in hot flashes 2
    • 75mg daily: 61% reduction in hot flashes 2
    • 150mg daily: 61% reduction in hot flashes (no additional benefit over 75mg) 2

The optimal dose appears to be 75mg daily, as higher doses (150mg) don't provide additional benefit but may increase side effects 1.

Administration Protocol

  1. Starting dose: 37.5mg daily for 7 days
  2. Maintenance dose: Increase to 75mg daily if needed 3
  3. Duration: The optimal treatment duration is unknown, but efficacy has been demonstrated in studies lasting 4-12 weeks 1
  4. Discontinuation: Gradual tapering is recommended to prevent discontinuation symptoms 1

Comparative Efficacy

Venlafaxine has been shown to be:

  • More effective than clonidine for hot flashes in breast cancer patients 4
  • Preferred by patients over gabapentin (68% vs 32%) despite similar efficacy in reducing hot flashes 3
  • Less effective than estrogen therapy, though still clinically significant 1

Side Effects to Monitor

  • Common: Dry mouth, decreased appetite, nausea, constipation 2
  • Less common: Headache, insomnia, somnolence, dizziness 5
  • Note: Side effects are dose-dependent and generally mild to moderate 1

Important Considerations

  • Response variability: There is marked variability in individual response, with some women experiencing significant improvement while others may have minimal benefit or even worsening of symptoms 1
  • Discontinuation: When stopping venlafaxine, gradual tapering is essential to prevent withdrawal symptoms due to its short half-life 1
  • Drug interactions: For patients taking tamoxifen, venlafaxine has less potential to interfere with tamoxifen metabolism compared to some other antidepressants 1

Venlafaxine represents an effective non-hormonal option for managing hot flashes, particularly for women who cannot or choose not to use hormone therapy, with relatively rapid onset of action and good tolerability at the recommended doses.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010

Research

Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.

Annals of oncology : official journal of the European Society for Medical Oncology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.